Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Sf-Stk kinase activity and the Grb2 binding site are required for Epo-independent growth of primary erythroblasts infected with Friend virus

Abstract

During the initial stage of Friend virus-induced erythroleukemia in mice, interaction of the viral protein gp55 with the erythropoietin receptor, and other host factors, drives the expansion of erythroid precursor cells. Recently, we demonstrated that the Friend virus susceptibility locus, Fv2, which is required for the expansion of infected cells, encodes a naturally occurring, N-terminally truncated form of the Stk receptor tyrosine kinase (Sf-Stk). Here we show that in vitro expression of Sf-Stk confers Friend virus sensitivity to erythroid progenitor cells from Fv2rr mice. Furthermore, our data reveal that Sf-Stk kinase activity and Y436, but not Y429, are required for Epo-independent colony formation following Friend virus infection. Introduction of a mutation that results in failure to bind Grb2 abrogates the ability of Sf-Stk to induce colonies in response to Friend virus, while the Grb2 binding site from EGFR restores this response. Consistent with the ability of Grb2 to recruit SOS and Gab1, the Ras/MAPK and PI3K pathways are activated by Sf-Stk, and both of these pathways are required for gp55-mediated erythroblast proliferation. These data clearly demonstrate a requirement for signaling through Sf-Stk in the Epo-independent expansion of Friend virus-infected cells, and suggest a pivotal role for Grb2 in this response.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Ben-David Y, Bernstein A . 1991 Cell 66: 831–834

  • Boccaccio C, Ando M, Tamagnone L, Bardelli A, Michiell P, Battistini C, Comoglio PM . 1998 Nature 391: 285–288

  • Bondurant MC, Koury MJ, Krantz SB . 1985 J. Gen. Virol. 66: 83–96

  • Clarke BJ, Axelrad AA, Shreeve MM, McLeod DL . 1975 Proc. Natl. Acad. Sci. USA 72: 3556–3560

  • Correll PH, Iwama A, Tondat S, Mayrhofer G, Suda T, Bernstein A . 1997 Genes and Function 1: 69–83

  • D'Andrea AD . 1992 Cancer Surveys 15: 19–36

  • Fixman ED, Fournier TM, Kamikura DM, Naujokas MA, Park M . 1996 J. Biol. Chem. 271: 13116–13122

  • Fournier T, Kamikura D, Teng K, Park M . 1996 J. Biol. Chem. 271: 22211–22217

  • Gong Q, Cheng A, Akk A, Alberola-Ila J, Gong G, Pawson T, Chan A . 2001 Nat. Immunol. 2: 29–36

  • Hoatlin ME, Kabat D . 1995 Trends Micro. 3: 51–57

  • Huff JL, Jelinek MA, Borgman CA, Lansing TJ, Parsons JT . 1993 Proc. Natl. Acad. Sci. USA 90: 6140–6144

  • Iwama A, Okano K, Sudo T, Matsuda Y, Suda T . 1994 Blood 83: 3160–3169

  • Iwama A, Yamaguchi N, Suda T . 1996 EMBO J. 15: 5866–5875

  • Jeffers M, Schmidt L, Nakaigawa N, Webb CP, Weirich G, Kishida Y, Zbar B, Vande Woude GF . 1997 Proc. Natl. Acad. Sci. USA 94: 11445–11450

  • Leonard EJ . 1997 Ciba Found. Symp. 212: 183–191

  • Li J-P, D'Andrea AD, Lodish HF, Baltimore D . 1990 Nature 343: 762–764

  • Liu Q-P, Fruit K, Ward J, Correll PH . 1999 J. Immunol. 163: 6606–6613

  • Longati P, Bardelli A, Ponzetto C, Naldini L, Comoglio PM . 1994 Oncogene 9: 49–57

  • Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG, Duffy T, Jacobs P, Tang LH, Modlin I . 1996 Nat. Genet. 12: 312–314

  • Maina F, Casagranda F, Audero E, Simeone A, Comoglio PM, Klein R, Ponzetto C . 1996 Cell 87: 531–542

  • Moreau-Gachelin F, Tavitian A, Tambourin P . 1988 Nature 331: 277–280

  • Moriyama Y, Tsujimura T, Hashimoto K, Morimoto M, Kitayama H, Matsuzawa Y, Kitamura Y, Kanakura Y . 1996 J. Biol. Chem. 271: 3347–3350

  • Mowat M, Cheng A, Kimura N, Bernstein A, Benchimol S . 1985 Nature 314: 633–636

  • Nguyen L, Holgado-Madruga M, Maroun C, Fixman ED, Kamikura D, Fournier T, Charest A, Tremblay ML, Wong AJ, Park M . 1997 J. Biol. Chem. 272: 20811–20819

  • Nishigaki K, Hanson C, Ohashi T, Thompson D, Muszynski K, Ruscetti S . 2000 J. Virol. 74: 3037–3045

  • Nishigaki K, Thompson D, Hanson C, Yugawa T, Ruscetti S . 2001 J. Virol. 75: 7893–7903

  • Ohashi T, Masuda M, Ruscetti SK . 1995 Blood 85: 1454–1462

  • Park CY, Hayman MJ . 1999 J. Biol. Chem. 274: 7583–7590

  • Peace BE, Hughes MJ, Degen SJ, Waltz SE . 2001 Oncogene 20: 6142–6151

  • Persons DA, Paulson RF, Loyd MR, Herley MT, Bodner SM, Bernstein A, Correll PH, Ney PA . 1999 Nat. Genet. 23: 159–165

  • Piao X, Paulson R, van der Geer P, Pawson T, Bernstein A . 1996 Proc. Natl. Acad. Sci. USA 93: 14665–14669

  • Santoro MM, L P, Minetto M, Orecchia S, Cilli M, Gaudino G . 1998 Oncogene 17: 741–749

  • Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJ, Walther MM, Tsui LC, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Storkel S, Lerman MI, Linehan WM, Zbar B . 1997 Nat. Genet. 16: 68–73

  • Smith DR, Vogt PK, Hayman MJ . 1989 Proc. Natl. Acad. Sci. USA 86: 5291–5295

  • Songyang Z, Shoelson S, McGlade J, Olivier P, Pawson T, Bustelo X, Barbacid M, Sabe H, Hanafusa H, Yi T, Ren R, Baltimore D, Ratnofsky S, Feldman R, Cantley L . 1994 Mol. Cell. Biol. 14: 2777–2785

  • Stefan M, Koch A, Mancini A, Mohr A, Weidner K, Niemann H, Tamura T . 2001 J. Biol. Chem. 276: 3017–3023

  • Yamamura Y, Senda H, Kageyama Y, Matsuzaki T, Noda M, Ikawa Y . 1998 Mol. Cell. Biol. 18: 1172–1180

  • Zhen Z, Giordano S, Longati P, Medico E, Campiglio M, Comoglio PM . 1994 Oncogene 9: 1691–1697

Download references

Acknowledgements

The authors would like to thank Drs A August and A Henderson for their technical advice concerning autophosphorylation studies and retroviral transduction techniques and Dr T Suda for the Stk docking site tyrosine mutant constructs. This work was supported in part by an American Cancer Society Postdoctoral Fellowship PF-01-121-01-LIB (LD Finkelstein), National Institutes of Health (NIH) grant RO1 HL66471 (PH Correll and RF Paulson), and a Junior Faculty Scholar Award from the American Society of Hematology (PH Correll).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pamela H Correll.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Finkelstein, L., Ney, P., Liu, QP. et al. Sf-Stk kinase activity and the Grb2 binding site are required for Epo-independent growth of primary erythroblasts infected with Friend virus. Oncogene 21, 3562–3570 (2002). https://doi.org/10.1038/sj.onc.1205442

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205442

Keywords

This article is cited by

Search

Quick links